...r transfusion needs. A recognized leader in autotr...ay to add the safety of microfiltration for a vari...ve or postoperative applications, autologous or ho...rovides both convenience and versatility in the re...
This high technology cast plaster cutter saw is very easy and comfortable to use.
Designed to reduce noise to a minimum results in less emotional trauma for patients and less hearing trauma for the clinician. The innovative motor plus saw design delivers high power in a smaller, l
The True/Fix Cannulated Bone Screw System contains 7.0mm large cannulated bone screws and 3.5mm cortical and 4.0mm cannulated cancellous bone screws.
Medicine Products:(Date:5/22/2008)... PHOENIX, May 22 /PRNewswire/ -- TriWest Heal...Telly Awards in the 28th Annual Telly Awards,compe...r the visual arts,community., The awards recogniz...ideo as an effective medium to reach military serv...sources and clinical support tools., "At TriWest,...
(Date:5/22/2008)... IRVINE, Calif., May 22 /PRNewswire/ -- Accen...een formally accepted into Sun,s Authorized,Subcon...Delivery Workforce,to provide improved integration...w relationship, Accenx Technologies will see subst...nt roster, develop a closer working,relationship w...
(Date:5/22/2008)... , LOS ANGELES, May 22 /PRNewswire-USNewswire/ -...used on prevention and recovery from Autism,ADHD ... of the organization,through three major steps:, ...ave joined the Board,of Directors., Ms. McCarthy ...other,who recovered her son Evan from autism. Her ...
(Date:5/22/2008)... First Product That Gives Consumers an All-Natura...robiotics & Prebiotic Fiber, JERICHO, N.Y., May 2...ottage cheese with more healthy benefits hits supe...e Health Cottage Cheese with Pro-Active,Nutrients....ed All-Natural,cottage cheese product, Friendship ...
Breaking Medicine News(10 mins):Health News:TriWest Receives National Awards for Innovative Video Communications to Military Community 2Health News:TriWest Receives National Awards for Innovative Video Communications to Military Community 3Health News:Accenx Technologies Joins Sun's Authorized Subcontractor Program 2Health News:Generation Rescue to Target Treatment-Based Research for Autism and ADHD - Jenny McCarthy, Deirdre Imus, and Katie Wright Join Board 2Health News:Generation Rescue to Target Treatment-Based Research for Autism and ADHD - Jenny McCarthy, Deirdre Imus, and Katie Wright Join Board 3Health News:New Friendship Cottage Cheese Boosts Digestive & Bone Health 2Health News:New Friendship Cottage Cheese Boosts Digestive & Bone Health 3...Doctors at Indore surgically removed an arrowhead,...ago. Till the weapon was removed surgically the tr...nd normally as if nothing has happened. Gajuram, ...l 7 by an arrow by fellow tribesman Kaliya when he...
...Students in Haryana will get a chance to learn yog...ga in the government schools across// the state. ...he was keen to introduce the yoga classes from thi... attended Ramdev's yoga training camp at the indus...
...The years have not lessened the pain of losing the...red Ashok Trivedi and his wife Meenakshi to run fr...hildren are similarly afflicted. The Trivedis we...ed in 1997. They had tried their best to save her,...
...Researchers at Harvard Medical School have been ab...iphering the value that people attach// to differe...he nature of decision making, when a person needs ...le. To quote the words of Camillo Padoa-Schioppa,...
Other Medicine News:Health News:Distressed Couple Assists Parents Of Mentally Challenged Kids 2Health News:Decision-Making Enabled By Neurons: Value Assigned To Available Choices. 2(Date:5/21/2008)... Four HUMIRA Patients from CHARM Study in Remissio...on at Two Years, ABBOTT PARK, Ill., May 21 /PRNew...ension study of two Abbott pivotal studies, CHARM ...e Crohn,s patients treated with,HUMIRA(R) (adalimu...nical,response, respectively, according to data pr...
(Date:5/21/2008)...SAN FRANCISCO, Calif., May 21 /PRNewswire-FirstCal... ) today announced the initiation of the,REVEAL-1 ...Phase 2 clinical,trial of voreloxin (also known as...tic. The REVEAL-1 trial is being conducted in prev...id leukemia (AML) who are unlikely to,benefit from...
(Date:5/21/2008)...s Show Cystic Fibrosis Patients Cough More Than 60...-, SOUTH PLAINFIELD, N.J., May 21 /-...data suggesting that the quantification of cough,f... measure in cystic,fibrosis (CF). Cough is one of ...symptoms in CF. According to data presented today ...
(Date:5/21/2008)..., Germany, May 21 /-, - Re...s Front-line,Screen, Long-term data from a study ...how that women screened only with a human papillom...p moderate to severe cervical disease over,the nex...ology (the Pap,"smear"). The research followed nea...
Breaking Medicine Technology:Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 2Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 3Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 4Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 5Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 6Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission 7Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 2Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 3Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 4Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 5PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis 2PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis 3PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis 4Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap 2Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap 3Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap 4OHSU Cancer Institute researchers pinpoint how smoking causes cancer 19213 1OHSU Cancer Institute researchers pinpoint how smoking causes cancer 19213 2KORRES Q1 2008 Results 19208 1KORRES Q1 2008 Results 19208 2Yerkes researchers find link between psychological stress and overeating 19205 1Yerkes researchers find link between psychological stress and overeating 19205 2Study Finds More Than One in Two Women are Too Embarrassed to Discuss Vaginal Discomfort With Their Doctors 19200 1Study Finds More Than One in Two Women are Too Embarrassed to Discuss Vaginal Discomfort With Their Doctors 19200 2Study Finds More Than One in Two Women are Too Embarrassed to Discuss Vaginal Discomfort With Their Doctors 19200 3Study Finds More Than One in Two Women are Too Embarrassed to Discuss Vaginal Discomfort With Their Doctors 19200 4...ity of Abstracts Reflects Continued Growth of Eisa...May 31, 2007 /PRNewswire/ -- Eisai,announced today...ut,their oncology pipeline compounds have been acc...Clinical Oncology (ASCO),annual meeting. ASCO take...stracts reveal a growing and diverse oncology clin...
...E, Calif., May 30, 2007 /PRNewswire-FirstCall/ -- ...Phase II Uvidem,melanoma vaccine clinical trial an...ng cancer (NSCLC) vaccine clinical trial will be,p...Oncology (ASCO),43rd annual meeting in Chicago on ..., -- "Clinical and immunological responses i...
Other Medicine Technology:Clinical Data on Eisai's Oncology Pipeline to be Presented at ASCO,Annual Meeting 2Clinical Data on Eisai's Oncology Pipeline to be Presented at ASCO,Annual Meeting 3Clinical Data on Eisai's Oncology Pipeline to be Presented at ASCO,Annual Meeting 4IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 2IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 3IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 4IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 5IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 6